BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21279523)

  • 1. Allergy to human insulin and specific immunotherapy with glargine; case report with review of literature.
    Hasani-Ranjbar S; Fazlollahi MR; Mehri A; Larijani B
    Acta Diabetol; 2012 Feb; 49(1):69-73. PubMed ID: 21279523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin allergy: clinical manifestations and management strategies.
    Heinzerling L; Raile K; Rochlitz H; Zuberbier T; Worm M
    Allergy; 2008 Feb; 63(2):148-55. PubMed ID: 18186805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allergy to human insulin. Case reports on 3 patients].
    Nagel C; Talaulicar M; Humbert I; Willms B
    Dtsch Med Wochenschr; 1988 Jun; 113(25):1013-6. PubMed ID: 3289875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin.
    Adachi A; Fukunaga A; Horikawa T
    Int J Dermatol; 2004 Aug; 43(8):597-9. PubMed ID: 15304187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting insulin allergy in a diabetic child.
    Mastrorilli C; Rizzuti L; Cangelosi AM; Iovane B; Chiari G; Caffarelli C
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):174-177. PubMed ID: 28368217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
    Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
    Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I allergy to insulin: case report and review of localized and systemic reactions to insulin.
    Hoffman AG; Schram SE; Ercan-Fang NG; Warshaw EM
    Dermatitis; 2008; 19(1):52-8. PubMed ID: 18346398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical, clinical approach to the assessment and management of suspected insulin allergy.
    Jacquier J; Chik CL; Senior PA
    Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
    Prescrire Int; 2006 Oct; 15(85):163-7. PubMed ID: 17121210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of insulin allergy successfully managed using multihexamer-forming insulin degludec combined with liraglutide.
    Fujishiro M; Izumida Y; Takemiya S; Kuwano Y; Takamoto I; Suzuki R; Yamauchi T; Ueki K; Kadowaki T
    Diabet Med; 2016 Nov; 33(11):e26-e29. PubMed ID: 26485621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
    Juhaeri J; Gao S; Dai WS
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin allergy: an approach to therapy.
    Bucholtz HK
    South Med J; 1976 Sep; 69(9):1118-20. PubMed ID: 135348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful desensitization by glargine administration in a patient with insulin allergy: a case report.
    Hara M; Izumida Y; Sato N; Ohashi K; Osuga J; Tobe K; Tsukamoto K; Kadowaki T
    Diabetes Res Clin Pract; 2009 Jun; 84(3):e48-9. PubMed ID: 19286270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delayed hypersensitivity to protamine and immediate hypersensitivity to insulin].
    Köllner A; Senff H; Engelmann L; Kalveram KJ; Velcovsky HG; Haneke E
    Dtsch Med Wochenschr; 1991 Aug; 116(33):1234-8. PubMed ID: 1831420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin allergy in type II diabetes: rapid desensitization].
    Ruíz Barrera E; Martínez-Cario Cueto S
    Rev Alerg Mex; 1994; 41(1):19-24. PubMed ID: 8087231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin allergy: background, diagnosis and treatment].
    Wonders J; Eekhoff EM; Heine R; Bruynzeel DP; Rustemeyer T
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2783-8. PubMed ID: 16385830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.